Overview
Viatris Inc
Latest 10-K: FY2025, filed Feb 26, 2026 · Open the 10-K (Inline XBRL) ↗
- Revenue
- $14.30B
- 3.0%YoYdown from FY2024
- TotalRevenue
- Gross profit
- $5.01B
- 10.8%YoYdown from FY2024
- GrossProfit
- Operating income
- -$2.66B
- 26467.3%YoYdown from FY2024
- OperatingIncome
- Diluted EPS
- -$3.00
- n/mYoY
- EPSDiluted
- Free cash flow
- $1.94B
- 2.0%YoYdown from FY2024
At a glance
Growth
- Viatris Inc reported revenue of $14.30B for fiscal 2025, down 3.0% from fiscal 2024.
- Revenue grew faster than the median S&P 500 member in 1 of the last 5 fiscal years.
Profitability
- Operating margin was -18.6%.
Per share
- Diluted EPS was -$3.00.
Written from the filed figures on this page by fixed rules — no AI.
Data as of Oct 31, 2026 · Sources: SEC EDGAR 10-K
Financial statements
Annual figures from the 10-K, most recent fiscal year first.
Income Statement
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $14.30B3.0%down Benchmark median 6.4% | $14.74B4.5%down Benchmark median 4.5% | $15.43B5.1%down Benchmark median 4.8% | $16.26B9.1%down Benchmark median 10.3% | $17.89B49.7%up Benchmark median 13.8% | -5.4% Benchmark median 6.6% |
| Gross Profit Median of 315 / 498 | $5.01B10.8%down Benchmark median 6.8% | $5.62B12.7%down Benchmark median 5.5% | $6.44B0.9%down Benchmark median 5.2% | $6.50B16.5%up Benchmark median 8.3% | $5.58B46.9%up Benchmark median 15.7% | -2.6% Benchmark median 6.2% |
| Operating Income Median of 373 / 498 | negative: -$2.66B26467.3%down Benchmark median 7.3% | $0.01B98.7%down Benchmark median 7.4% | $0.77B52.6%down Benchmark median 4.9% | $1.61Bn/m Benchmark median 7.5% | negative: -$0.03Bn/m Benchmark median 23.5% | n/m Benchmark median 7.2% |
| Net Income | — | — | — | — | — | — Benchmark median 4.1% |
| EPS (Diluted) | negative: -$3.00n/m Benchmark median 6.2% | negative: -$0.531160.0%down Benchmark median 7.9% | $0.0597.1%down Benchmark median 1.9% | $1.71n/m Benchmark median 1.5% | negative: -$1.05‡n/m Benchmark median 34.8% | n/m Benchmark median 5.6% |
‡ Share basis changed between these years (stock split or reverse split).
Balance Sheet
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Total Assets | $37.19B10.4%down Benchmark median 5.6% | $41.50B13.0%down Benchmark median 3.4% | $47.69B4.7%down Benchmark median 4.1% | $50.02B8.8%down Benchmark median 2.2% | $54.84B10.9%down Benchmark median 6.7% | -9.3% Benchmark median 4.7% |
| Total Liabilities Median of 357 / 498 | $22.48B1.7%down Benchmark median 6.4% | $22.87B16.0%down Benchmark median 1.9% | $27.22B6.0%down Benchmark median 2.9% | $28.95B15.7%down Benchmark median 2.0% | $34.35B11.0%down Benchmark median 5.2% | -10.1% Benchmark median 4.4% |
| Stockholders' Equity | $14.71B21.1%down Benchmark median 6.8% | $18.64B9.0%down Benchmark median 5.4% | $20.47B2.9%down Benchmark median 7.3% | $21.07B2.8%up Benchmark median 2.5% | $20.49B10.7%down Benchmark median 9.0% | -8.0% Benchmark median 6.1% |
| Cash & Equivalents | $1.32B80.0%up Benchmark median 5.2% | $0.73B25.9%down Benchmark median 1.9% | $0.99B21.3%down Benchmark median 6.7% | $1.26B79.7%up Benchmark median -8.6% | $0.70B17.0%down Benchmark median -2.9% | 17.2% Benchmark median 2.0% |
| Total Debt | $14.41B2.6%up Benchmark median 2.1% | $14.05B22.5%down Benchmark median 0.2% | $18.13B5.9%down Benchmark median 0.3% | $19.27B16.5%down Benchmark median 0.1% | $23.09B10.6%down Benchmark median -0.1% | -11.1% Benchmark median 4.3% |
Cash Flow Statement
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.32B0.6%up Benchmark median 6.3% | $2.30B20.6%down Benchmark median 4.8% | $2.90B3.3%down Benchmark median 9.9% | $3.00B0.6%down Benchmark median -0.7% | $3.02B144.9%up Benchmark median 10.7% | -6.4% Benchmark median 7.0% |
| Capital Expenditures | $378.80M16.2%up Benchmark median 5.4% | $326.00M13.5%down Benchmark median 2.8% | $377.00M7.1%down Benchmark median 11.3% | $406.00M11.2%down Benchmark median 14.0% | $457.20M88.1%up Benchmark median 8.1% | -4.6% Benchmark median 9.0% |
| Free Cash Flow Median of 378 / 498 | $1.94B2.0%down Benchmark median 7.3% | $1.98B21.6%down Benchmark median 6.1% | $2.52B2.7%down Benchmark median 8.8% | $2.59B1.3%up Benchmark median -11.3% | $2.56B158.9%up Benchmark median 10.2% | -6.7% Benchmark median 4.9% |
n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.
Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology
Ratios & valuation
FY2025Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.
Valuation · Earnings yield
What a dollar of market value earned
n/m
Wall Street
on net earnings
FY2024 n/m
— Not reported
Value investor
on free cash flow
FY2024 — Not reported
How it’s calculated
Wall Street · on net earnings
Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)
pe_ratio (ratio table)
P/E n/mValue investor · on free cash flow
(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)
free cash flow ÷ market cap
Quality · Return on capital
Profit earned on the money in the business
— Not reported
Wall Street
ROE: net income ÷ equity
FY2024 — Not reported
negative: −6.9%
Value investor
ROIC: after-tax operating profit ÷ invested capital
FY2024 0.0%
How it’s calculated
Wall Street · ROE: net income ÷ equity
Net income ÷ average stockholders' equity (start and end of year), including noncontrolling interests. Buybacks shrink equity and lift it.
return_on_equity (ratio table)
Value investor · ROIC: after-tax operating profit ÷ invested capital
Operating profit after tax ÷ invested capital (total assets − cash − non-interest-bearing current liabilities), so leverage cannot flatter it
roic (ratio table)
Quality · Cash margin
Cash profit kept from each dollar of sales
0.9%
Wall Street
EBITDA margin
FY2024 19.7%
13.5%
Value investor
Free-cash-flow margin
FY2024 13.4%
Gap +12.6 pts: Value-investor figure 12.6 points higher
How it’s calculated
Wall Street · EBITDA margin
EBITDA ÷ revenue
ebitda ÷ revenue
Value investor · Free-cash-flow margin
(Operating cash flow − capital expenditures) ÷ revenue: taxes, interest, working capital and capex all paid
free cash flow ÷ revenue
Balance sheet · Liquidity
Short-term assets per dollar of bills due within a year
1.38×
Wall Street
Current ratio
FY2024 1.65×
0.82×
Value investor
Quick ratio, inventory excluded
FY2024 0.98×
Gap −0.56×: Value-investor figure 0.56 lower
How it’s calculated
Wall Street · Current ratio
Current assets ÷ current liabilities
current_ratio (ratio table)
Value investor · Quick ratio, inventory excluded
(Current assets − inventory) ÷ current liabilities
quick_ratio (ratio table)
Balance sheet · Debt cover
How many times one year of earnings repays all debt
0.01×
Wall Street
EBITDA ÷ total debt
FY2024 0.21×
0.13×
Value investor
FCF ÷ total debt
FY2024 0.14×
Gap +0.12×: Value-investor figure 0.12 higher
How it’s calculated
Wall Street · EBITDA ÷ total debt
EBITDA ÷ total debt (short-term + long-term)
ebitda ÷ total debt
Value investor · FCF ÷ total debt
Free cash flow ÷ total debt: what is actually left to repay it
free cash flow ÷ total debt
Balance sheet · Interest cover
How many times earnings pay the year's interest
0.3×
Wall Street
EBITDA ÷ interest
FY2024 5.3×
negative: −5.7×
Value investor
EBIT ÷ interest
FY2024 0.0×
Gap −6.0×: Value-investor figure 6.0 lower
How it’s calculated
Wall Street · EBITDA ÷ interest
EBITDA ÷ interest expense
ebitda_interest_coverage (ratio table)
Value investor · EBIT ÷ interest
Operating income ÷ interest expense
interest_coverage (ratio table)
Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.
Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.
Smart money
Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.
Peers, filings & research
Research Reports
No published research on VTRS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on VTRS and publish the result to your public profile.
Cite this page
Data as of Oct 31, 2026. Canonical address: https://valuein.biz/data/VTRS
Valuein. (2026, October 31). Viatris Inc (VTRS) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/VTRS
@misc{valuein_vtrs_2026,
author = {{Valuein}},
title = {Viatris Inc (VTRS) financial statements, earnings power and smart-money summary},
year = {2026},
howpublished = {\url{https://valuein.biz/data/VTRS}},
note = {Data as of 2026-10-31; source: SEC EDGAR filings}
}10-K filed Feb 26, 2026 · accession 0001792044-26-000013
Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.
point-in-time · survivorship-free · every number traceable to its SEC filing
Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.